Modification of the response to opioid and nonopioid drugs by chronic opioid antagonist treatment.
Chronic exposure to opioid antagonists increases the analgesic actions of opioids such as morphine. In the present studies, morphine's analgesic potency was increased (supersensitivity) following an 8 day subcutaneous naltrexone implant in mice, but not following a 1 day implant. Supersensitivity was maximal 24hr following the 8 day implant and declined linearly and had returned to control levels by 120hr. Implantation of naltrexone pellets for 8 days was found to increase the relative analgesic potency of methadone by 120%, while the lethal potency of cocaine was slightly (19%), but significantly, decreased. In contrast, identical treatment did not alter the potency of the benzodiazepine alprazolam to induce ataxia.
Yoburn
B C
BC
Department of Pharmaceutical Sciences, College of Pharmacy & Allied Health Professions, St. John's University, Jamaica, NY 11439.
Inturrisi
C E
CE
D000525:Alprazolam; D000698:Analgesia; D000818:Animals; D001259:Ataxia / Q000139:chemically induced; D003042:Cocaine / Q000494:pharmacology; D004343:Drug Implants; D007700:Kinetics; D008297:Male; D008691:Methadone; D051379:Mice; D009020:Morphine; D009270:Naloxone / Q000008:administration & dosage / Q000494:pharmacology*; D009294:Narcotics / Q000494:pharmacology*
D004343:Drug Implants; D009294:Narcotics; D009270:Naloxone; D009020:Morphine; D003042:Cocaine; D008691:Methadone; D000525:Alprazolam